Deep Learning for Diagnosing Patients with Rare Genetic Diseases

There are over 7,000 unique rare diseases, some of which affecting 3,500 or fewer patients in the US. Due to clinicians’ limited experience with such diseases and the considerable heterogeneity of their clinical presentations, many patients with rare genetic diseases remain undiagnosed. While artificial intelligence has demonstrated success in assisting diagnosis, its success is usually contingent on the availability of large labeled datasets.

Here, we present SHEPHERD, a deep learning approach for multi-faceted rare disease diagnosis. SHEPHERD is guided by existing knowledge of diseases, phenotypes, and genes to learn novel connections between a patient’s clinico-genomic information and phenotype and gene relationships. We train SHEPHERD exclusively on simulated patients and evaluate on a cohort of 465 patients representing 299 diseases (79% of genes and 83% of diseases are represented in only a single patient) in the Undiagnosed Diseases Network. SHEPHERD excels at several diagnostic facets: performing causal gene discovery (causal genes are predicted at rank = 3.52 on average), retrieving “patients-like-me” with the same gene or disease, and providing interpretable characterizations of novel disease presentations.

SHEPHERD demonstrates the potential of artificial intelligence to accelerate the diagnosis of rare disease patients and has implications for the use of deep learning on medical datasets with very few labels.

Rare diseases affect 300-400 million people worldwide, yet each disease has a very low prevalence, affecting no more than 50 per 100,000 individuals. Due to their low prevalence, most front-line clinicians lack experience with the disorders, resulting in many specialty referrals and expensive clinical workups for patients across multiple years and institutions. Furthermore, patients with the same disorder can present variable symptoms, disease severity, and age of onset. These challenges make rare disease diagnosis extremely difficult; approximately 70% of individuals seeking a diagnosis and up to half of the suspected Mendelian conditions remain undiagnosed.

Given a set of phenotypes describing a patient’s clinical presentation, SHEPHERD performs a multi-faceted patient diagnosis to identify causal genes, retrieve “patients-like-me” with the same causal gene or disease, or provide interpretable characterizations of novel disease presentations. SHEPHERD assists in the rare disease diagnosis at multiple points:

  • to find similar patients after the patient’s clinical workup,
  • to identify candidate genes after genome sequencing analysis or in conjunction with the clinical case review, and
  • to characterize the patient’s disease and find other patients with the same causal gene or disease.

Overview of SHEPHERD

SHEPHERD is first deep learning approach for individualized diagnosis of rare genetic diseases. It provides multi-faceted diagnosis of patients with rare genetic conditions. SHEPHERD operates at multiple points throughout the rare disease diagnosis process to perform causal gene discovery, retrieve “patients-like-me” with similar conditions, and provide interpretable names for novel disease presentations.

To overcome the limitations of supervised AI, SHEPHERD performs label-efficient training via knowledge-grounded metric learning, a deep learning paradigm uniquely suited for diagnostic analyses where patient diagnostic labels are incredibly scarce. This capability is achieved by projecting patient phenotypes in an embedding space whose geometry is optimized by the broader knowledge of phenotypes and genes.

When a new patient arrives, SHEPHERD projects the patient into the embedding space such that the patient is close to their most promising causal gene and disease and other patients with the same gene or disease. Using this embedding space for prediction, SHEPHERD nominates a patient’s genes and diseases even when no other patients are diagnosed with the same disease.

Evaluation on external patient cohorts

We evaluate SHEPHERD on an external cohort of patients in the Undiagnosed Diseases Network (UDN), a nationwide US study with 12 clinical sites that diagnose patients with rare, difficult to diagnose genetic conditions. SHEPHERD identifies the correct causal gene in 40% of patients spanning 16 disease areas.

Further, we show that SHEPHERD produces models with strong predictive performance across disease areas, clinical sites, and diagnosis years, successfully mitigating data mismatches between patient groups and pointing to SHEPHERD’s ability to minimize model performance gaps between patient groups.

SHEPHERD also generates meaningful patient representations that capture patient similarity and enable retrieval of “patients-like-me” with similar genetic conditions. Finally, our analyses demonstrate that SHEPHERD can nominate the correct diagnosis for patients with novel genetic diseases and provide interpretable characterizations of novel disease presentations.

Publication

Deep Learning for Diagnosing Patients with Rare Genetic Diseases
Emily Alsentzer*, Michelle M. Li*, Shilpa N. Kobren, Undiagnosed Diseases Network, Isaac S. Kohane and Marinka Zitnik
In Review 2023 [medRxiv]

* Equal Contribution

@article{alsentzer2022deep,
  title={Deep learning for diagnosing patients with rare genetic diseases},
  author={Alsentzer, Emily and Li, Michelle M and Kobren, Shilpa N and Undiagnosed Diseases Network and Kohane, Isaac S and Zitnik, Marinka},
  journal={medRxiv},
  pages={2022--12},
  url={https://www.medrxiv.org/content/10.1101/2022.12.07.22283238},
  year={2022},
  publisher={Cold Spring Harbor Laboratory Press}
}

Data availability

Datasets are available for download via Harvard Dataverse. To maintain the directory structure while downloading the files, make sure to select all files and download in the original format. We provide the following datasets for training SHEPHERD:

  • Rare disease knowledge graph
  • Disease-split train and validation sets for simulated patients
  • A cohort of MyGene2 patients

While the UDN dataset cannot be released in its entirety due to privacy concerns, anonymized UDN data has been deposited in dbGaP (accession phs001232) and PhenomeCentral. Phenotypes and causal variants and genes related to UDN diagnoses are shared publicly in ClinVar.

Code availability

Pytorch implementation of SHEPHERD is available in the GitHub repository.

We also provide an interactive demo to explore SHEPHERD’s predictions through a visual interface in the HuggingFace Space.

Authors

Latest News

Nov 2024:   Ayush Noori Selected as a Rhodes Scholar

Congratulations to Ayush Noori on being named a Rhodes Scholar! Such an incredible achievement!

Nov 2024:   PocketGen in Nature Machine Intelligence

Oct 2024:   Activity Cliffs in Molecular Property Prediction

Oct 2024:   Knowledge Graph Agent for Medical Reasoning

Sep 2024:   Three Papers Accepted to NeurIPS

Exciting projects include a unified multi-task time series model, a flow-matching approach for generating protein pockets using geometric priors, and a tokenization method that produces invariant molecular representations for integration into large language models.

Sep 2024:   TxGNN Published in Nature Medicine

Aug 2024:   Graph AI in Medicine

Excited to share a new perspective on Graph Artificial Intelligence in Medicine in Annual Reviews.

Aug 2024:   How Proteins Behave in Context

Harvard Medicine News on our new AI tool that captures how proteins behave in context. Kempner Institute on how context matters for foundation models in biology.

Jul 2024:   PINNACLE in Nature Methods

PINNACLE contextual AI model is published in Nature Methods. Paper. Research Briefing. Project website.

Jul 2024:   Digital Twins as Global Health and Disease Models of Individuals

Paper on digitial twins outlining strategies to leverage molecular and computational techniques to construct dynamic digital twins on the scale of populations to individuals.

Jul 2024:   Three Papers: TrialBench, 3D Structure Design, LLM Editing

Jun 2024:   TDC-2: Multimodal Foundation for Therapeutics

The Commons 2.0 (TDC-2) is an overhaul of Therapeutic Data Commons to catalyze research in multimodal models for drug discovery by unifying single-cell biology of diseases, biochemistry of molecules, and effects of drugs through multimodal datasets, AI-powered API endpoints, new tasks and benchmarks. Our paper.

May 2024:   Broad MIA: Protein Language Models

Apr 2024:   Biomedical AI Agents

Mar 2024:   Efficient ML Seminar Series

We started a Harvard University Efficient ML Seminar Series. Congrats to Jonathan for spearheading this initiative. Harvard Magazine covered the first meeting focusing on LLMs.

Mar 2024:   UniTS - Unified Time Series Model

UniTS is a unified time series model that can process classification, forecasting, anomaly detection and imputation tasks within a single model with no task-specific modules. UniTS has zero-shot, few-shot, and prompt learning capabilities. Project website.

Mar 2024:   Weintraub Graduate Student Award

Michelle receives the 2024 Harold M. Weintraub Graduate Student Award. The award recognizes exceptional achievement in graduate studies in biological sciences. News Story. Congratulations!

Zitnik Lab  ·  Artificial Intelligence in Medicine and Science  ·  Harvard  ·  Department of Biomedical Informatics